Start Date
September 1, 2016
Primary Completion Date
September 1, 2016
Study Completion Date
September 1, 2016
PEMF
The PEMF device (Rio Grande Neurosciences - RGN) the investigators would be testing has been shown to have significant anti-inflammatory effects in animals and humans and an excellent safety profile in several clinical studies. Key findings demonstrated that PEMF-treated rodents with a closed-head TBI exhibited a 5-fold decrease in IL-1b in the cerebral spinal fluid, an outcome associated with decreased neuropathology and improved function.
Collaborators (1)
Rio Grande Neurosciences
INDUSTRY
Spaulding Rehabilitation Hospital
OTHER